Literature DB >> 9327452

Enhanced anti-inflammatory effects of Cu, Zn-superoxide dismutase delivered by genetically modified skin fibroblasts in vitro and in vivo.

K Okumura1, K Nishiguchi, Y Tanigawara, S Mori, S Iwakawa, F Komada.   

Abstract

PURPOSE: The purpose of this work was to evaluate the anti-inflammatory effects of secretable human Cu, Zn-superoxide dismutase (hSOD) delivered by genetically modified skin fibroblasts in vitro and in vivo.
METHODS: Rat skin fibroblasts were transfected with pRc/CMV-ILSOD including secretable SOD-coding cDNA. The effects of host and transformants on oxidative stress in vitro models using the xanthine/xanthine oxidase (X/XO) system were examined to study the paracrine SOD action. The anti-inflammatory effects by transplantation of host and transformants were evaluated in an acute inflammation model, carrageenin-induced paw edema, in rats.
RESULTS: The transformants (ILSOD cells) secreted SOD protein into the extracellular space, and the extracellular SOD activity in ILSOD cells cultures was significantly increased compared with that in host cell cultures. ILSOD cells diminished the cytotoxic activity by X/XO in a paracrine fashion. These protective effects of ILSOD cells against X/XO-induced cytotoxicity correlated well with the decrease in lipid peroxidation in the damaged cells. The in vivo study showed that transplantation of ILSOD cell suspensions into the hind paw in rats inhibited carrageenin-induced paw edema for at least 7 days, and the degree and the durability of these inhibitory effects were dependent on the number of ILSOD cells transplanted. These inhibitory effects of ILSOD cell suspensions were reduced by co-administration of antiserum for hSOD. Furthermore, the healing of paw edema caused by carrageenin was markedly enhanced by transplantation of ILSOD cells into the edemics hind paw.
CONCLUSIONS: The findings suggested that genetically modified skin fibroblasts are a suitable delivery system for obtaining an efficient and continuous supply of SOD to the target site, and this strategy may be a useful drug delivery system for therapeutic proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327452     DOI: 10.1023/a:1012115109525

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

Review 1.  Superoxide dismutases. An adaptation to a paramagnetic gas.

Authors:  I Fridovich
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

Review 2.  Free radicals and myocardial ischemia: overview and outlook.

Authors:  J M McCord
Journal:  Free Radic Biol Med       Date:  1988       Impact factor: 7.376

3.  Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma.

Authors:  W F Petrone; D K English; K Wong; J M McCord
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

4.  Secretion of human EGF and IgE in mammalian cells by recombinant DNA techniques; use of a IL-2 leader sequence.

Authors:  R Sasada; R Marumoto; K Igarashi
Journal:  Cell Struct Funct       Date:  1988-04       Impact factor: 2.212

5.  Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulation life and anti-inflammatory activity.

Authors:  P S Pyatak; A Abuchowski; F F Davis
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1980-07

6.  Implantation of genetically engineered fibroblasts into mice: implications for gene therapy.

Authors:  R F Selden; M J Skoskiewicz; K B Howie; P S Russell; H M Goodman
Journal:  Science       Date:  1987-05-08       Impact factor: 47.728

Review 7.  Clinical pharmacokinetics and delivery of bovine superoxide dismutase.

Authors:  G Jadot; A Vaille; J Maldonado; P Vanelle
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

8.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

9.  Effect of epidermal growth factor on Cu, Zn-superoxide dismutase expression in cultured fibroblasts from rat skin.

Authors:  K Nishiguchi; Y Kiyohara; F Komada; S Iwakawa; K Okumura
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

10.  Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat.

Authors:  N K Boughton-Smith; A M Deakin; R L Follenfant; B J Whittle; L G Garland
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more
  2 in total

1.  Regulation of exogenous gene expression by superoxide.

Authors:  Atsushi Kinoshita; Daisuke Kobayashi; Yukiya Saitoh; Naoto Tanabe; Katsuyoshi Uchino; Kohshi Nishiguchi; Katsuhiko Okumura; Fusao Komada
Journal:  Pharm Res       Date:  2006-10-18       Impact factor: 4.200

2.  Cell-penetrating superoxide dismutase attenuates oxidative stress-induced senescence by regulating the p53-p21(Cip1) pathway and restores osteoblastic differentiation in human dental pulp stem cells.

Authors:  Yoon Jung Choi; Jue Yeon Lee; Chong Pyoung Chung; Yoon Jeong Park
Journal:  Int J Nanomedicine       Date:  2012-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.